Transforming growth factor β alters plasminogen activator activity in human skin fibroblasts

Experimental Cell Research

Volumn 164, Issue 2, 1986, Pages 399-407

  Laiho, Marikki ^a   Saksela, Olli ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; EPIDERMAL GROWTH FACTOR; INSULIN; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR;

DRUG EFFICACY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST;

ANTIBODIES; CELLS, CULTURED; CYCLOHEXIMIDE; DRUG INTERACTIONS; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; HUMAN; INSULIN; PEPTIDES; PLASMINOGEN ACTIVATORS; PLATELET-DERIVED GROWTH FACTOR; SKIN; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0022530451     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-4827(86)90038-8     Document Type: Article

References (41)

1. Plasminogen Activators, Tissue Degradation, and Cancer
2. A study of proteases and protease-inhibitor complexes in biological fluids
3. Protease nexins: cell-secreted proteins which regulate extracellular serine proteases
4. Subunit structure of a high-affinity receptor for type beta-transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex.
5. Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha
6. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.
7. Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.
8. Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.